Although various LOX enzymes have been described to have pro-tumor or antitumor roles, and have been targeted in various cancers [107], the role of SPMs has been studied in inflammation-related cancer, such as colorectal cancer [108] and gastric cancer [109], and is an emerging field in other cancers [64]. Here, LOX is linked to colorectal cancer.